Company news

Scancell Holdings PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Director Award of Share Options

September 4, 2020

Funds awarded by Innovate UK for COVID-19 vaccine

August 27, 2020

Results of General Meeting

August 11, 2020

Shareholder circular

July 23, 2020

Result of Placing and Notice of General Meeting

July 22, 2020

Proposed Capital Raise

July 22, 2020

New publication highlights potential of Modi-1

June 24, 2020

Publication highlights potential of AvidiMab

June 12, 2020

Director salaries and award of share options

May 1, 2020

Scancell: Development of vaccine against COVID-19

April 24, 2020

Scancell to Present at Three Research Conferences

March 3, 2020

SCIB1 IND Application Approved

February 3, 2020

Third agreement signed for antibody platform

January 20, 2020

Director's Dealings

December 17, 2019

Second agreement signed for AvidiMab platform

December 16, 2019

New European Moditope patent allowed for grant

November 20, 2019

Posters at Cancer Immunotherapy Conference

September 26, 2019

First Collaboration Agreement for AvidiMab

September 4, 2019

Final Results for the year ended 30 April 2019

August 20, 2019

Update on the SCIB1 Phase 2 clinical trial

August 19, 2019

H1 2019 Business Update

July 1, 2019

Board Appointment

June 18, 2019

Share Subscription and Issue of Equity to Vulpes

June 13, 2019

Scancell and CRUK provide an update on SCIB2

May 20, 2019

Clinical Advisory Board and Update on Modi-1

May 10, 2019

UK approval to start SCIB1 Phase 2 trial

April 25, 2019

Japan patent for Moditope immunotherapy platform

April 8, 2019

Professor Lindy Durrant receives Waldenström award

March 21, 2019

Scancell strengthens IP portfolio

March 20, 2019

Update on Cancer Research UK's Grand Challenge

January 23, 2019

Appoints Heads of Research and Manufacturing

January 21, 2019

Scancell to Present at Two Conferences

November 12, 2018

Scancell to present at Proactive Investors Forum

November 1, 2018

Results of AGM

October 30, 2018

Identification of 2nd Moditope Cancer Vaccine

October 30, 2018

Update on SCIB1 Phase 2 Clinical Study

October 24, 2018

Final Results for the year ended 30 April 2018

September 25, 2018

Board Change

August 10, 2018

Agreement

August 9, 2018

Scancell exercises TriGrid commercial option

July 18, 2018

Grant of European patent for Moditope platform

May 23, 2018

Result of the Open Offer and PDMR Shareholdings

May 8, 2018

Result of Placing and Subscription and PDMR

April 18, 2018

Technology acquired from University of Nottingham

April 18, 2018

Proposed Placing, Subscription and Open Offer

April 18, 2018

Manufacturing agreement with The PolyPeptide Group

April 3, 2018

Scancell to present at the Calculus Investor Forum

February 16, 2018

Hardman Res. - Validating multiple opportunities

February 15, 2018

Collaboration agreement with ISA Pharmaceuticals

February 15, 2018

Publication highlights potential of SCIB1 therapy

February 12, 2018

← Newer news releases · Older news releases →

Calls

Decks

The 5 newest of 21 decks. Every deck is listed under its year.